Inside informationFrench
VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Valbiotis
- Filed
- 14/01/2025, 17:45
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- French
- AMF reference
- 006712_20250114